The Discriminative Stimulus Properties of Hallucinogenic and Dissociative Anesthetic Drugs.
Current Topics in Behavioral Neurosciences 2018 DOI: 10.1007/7854_2016_29 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Serotonin |
| Keywords | Discriminative stimulus properties Hallucinogens Psychedelics Sigma-1 receptor |
| Key findings | The mechanisms of discriminative stimulus effects of hallucinogenic and dissociative anesthetic drugs are not yet fully clear. |
Abstract
The subjective effects of drugs are related to the kinds of feelings they produce, such as euphoria or dysphoria. One of the methods that can be used to study these effects is the drug discrimination procedure. Many researchers have been trying to elucidate the mechanisms that underlie the discriminative stimulus properties of abused drugs (e.g., alcohol, psychostimulants, and opioids). Over the past two decades, patterns of drug abuse have changed, so that club/recreational drugs such as phencyclidine (PCP), 3,4-methylenedioxymethamphetamine (MDMA), ketamine, and cannabinoid, which induce perceptual distortions, like hallucinations, are now more commonly abused, especially in younger generations. In particular, the abuse of designer drugs, which aim to mimic the subjective effects of psychostimulants (e.g., MDMA or amphetamines), has been problematic. However, the mechanisms of the discriminative stimulus effects of hallucinogenic and dissociative anesthetic drugs are not yet fully clear. This chapter focuses on recent findings regarding hallucinogenic and dissociative anesthetic drug-induced discriminative stimulus properties in animals.
Comparable studies
Other narrative reviews on serotonin, most cited first.
Citations in the library
Cited by 4
- Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines Neuropharmacology December 15, 2022
- Dissociation and Temporality in Substance Abuse: A Clinical Phenomenological Overview. Psychopathology 2024
- Classics in Chemical Neuroscience: Dextromethorphan (DXM). ACS Chemical Neuroscience June 21, 2023
- The Pharmacology of Visual Hallucinations in Synucleinopathies. Frontiers in Pharmacology December 9, 2019
Cites 22
- Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy Journal of Psychopharmacology 2005
- Human Pharmacology of 3,4-Methylenedioxymeth-amphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects Journal of Clinical Psychopharmacology August 1, 2000
- Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. Journal of Neural Transmission September 12, 2009
- Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects. Psychopharmacology March 1, 2013
- Effects of Acute MDMA Intoxication on Mood and Impulsivity: Role of the 5-HT2 and 5-HT1 Receptors PLoS One July 10, 2012
and 17 more in the library